Calculator

    CHA₂DS₂-VASc Score Calculator

    The CHA₂DS₂-VASc score estimates annual stroke risk in non-valvular atrial fibrillation from seven weighted factors (CHF, hypertension, age, diabetes, prior stroke, vascular disease, sex). Anticoagulation is generally recommended at ≥2 in men and ≥3 in women.

    Session:empty

    Inputs

    Auto-fills fields as you type
    yrs

    Note: For non-valvular atrial fibrillation only. Does not apply to valvular AF, prosthetic valves, or moderate-to-severe mitral stenosis. Always pair with a bleeding-risk assessment (HAS-BLED) and shared decision-making.

    Formula

    Score = CHF (1) + HTN (1) + Age ≥75 (2) or 65–74 (1) + Diabetes (1) + Stroke/TIA/TE (2) + Vascular disease (1) + Female sex (1). Annual stroke risk (%) follows the Lip 2010 validation cohort.

    Worked example

    A 72-year-old woman with hypertension, heart failure, and a prior TIA scores: Age 65–74 = 1, Sex F = 1, HTN = 1, CHF = 1, Stroke = 2 → CHA₂DS₂-VASc 6, corresponding to ~9.7%/yr adjusted stroke risk.

    Benchmarks

    ScoreAnnual stroke riskRecommendation
    0 (male)0.2%No anticoagulation
    1 (female alone)0.6%No anticoagulation
    1 (male) / 2 (female)0.6–2.2%Shared decision — consider OAC
    ≥2 (male) / ≥3 (female)≥2.2%OAC recommended

    Adjusted annual stroke rates from Lip 2010. Interpretive thresholds per 2019 ACC/AHA/HRS focused update on AFib.

    Frequently asked

    When is anticoagulation recommended?

    Per the 2019 ACC/AHA/HRS focused update: score ≥2 in men and ≥3 in women meets the threshold for guideline-directed oral anticoagulation in non-valvular AF, absent contraindications.

    Is female sex always a risk factor?

    Female sex is a risk-modifier — it does not by itself indicate anticoagulation. A woman with a score of 1 (from sex alone) is treated like a man with a score of 0.

    How does CHA₂DS₂-VASc differ from CHADS₂?

    CHA₂DS₂-VASc adds age 65–74 (1), vascular disease (1), and female sex (1), and it weights age ≥75 as 2 rather than 1. It reclassifies many CHADS₂-low patients as intermediate and is now the guideline-preferred score.

    Does the calculator apply to atrial flutter?

    Yes — current guidelines recommend using CHA₂DS₂-VASc for stroke-risk assessment in atrial flutter as well as atrial fibrillation.

    Should I use CHA₂DS₂-VASc after ablation or cardioversion?

    Yes, at least in the short term. Long-term post-ablation anticoagulation decisions should be individualized because rhythm status alone does not fully modify baseline stroke risk.

    References

    1. 1.Lip GYH et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach. Chest 2010;137(2):263–72. https://doi.org/10.1378/chest.09-1584
    2. 2.January CT et al. 2019 AHA/ACC/HRS Focused Update on the Management of Patients With Atrial Fibrillation. Circulation 2019;140(2):e125–e151. https://doi.org/10.1161/CIR.0000000000000665
    3. 3.Friberg L et al. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Eur Heart J 2012;33(12):1500–10.

    This calculator is for general planning and educational purposes only and is not clinical, legal, billing, or financial advice. Confirm all reimbursement, regulatory, and financial figures with a qualified professional and your organization's current policies before acting on anything here.

    Related tools